These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 14208251)

  • 41. VASOACTIVE MEDIATORS AS THE "TRIGGER MECHANISM" OF ENDOTOXIN SHOCK.
    JACOBSON ED; MEHLMAN B; KALAS JP
    J Clin Invest; 1964 May; 43(5):1000-13. PubMed ID: 14171675
    [No Abstract]   [Full Text] [Related]  

  • 42. PLATELETS AND THE SHWARTZMAN PHENOMENON.
    LEVIN J; CLUFF LE
    J Exp Med; 1965 Feb; 121(2):235-46. PubMed ID: 14264269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin.
    Béguin S; Lindhout T; Hemker HC
    Thromb Haemost; 1989 Feb; 61(1):25-9. PubMed ID: 2749591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots.
    Semeraro F; Piro D; Rossiello MR; Ammollo T; Colucci M
    Thromb Haemost; 2007 Dec; 98(6):1208-14. PubMed ID: 18064315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. INFLUENCE OF CERTAIN DRUGS ON THE ADHESIVENESS OF HUMAN, RAT, AND RABBIT BLOOD PLATELETS IN VITRO.
    REBER K; STUDER A
    Thromb Diath Haemorrh; 1965 Jun; 13():428-38. PubMed ID: 14347866
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formation.
    Fiedel BA; Costello M; Gewurz H; Hussissian E
    Haemostasis; 1983; 13(2):89-95. PubMed ID: 6873753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets.
    Markwardt F; Hoffmann A; Stürzebecher J
    Haemostasis; 1983; 13(4):227-33. PubMed ID: 6618289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in the blood coagulation system induced by bacterial endotoxins. II. In vitro.
    McKAY DG; SHAPIRO SS; SHANBERGE JN
    J Exp Med; 1958 Mar; 107(3):369-76. PubMed ID: 13513906
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes.
    Niemetz J; Marcus AJ
    J Clin Invest; 1974 Dec; 54(6):1437-43. PubMed ID: 4612059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PROTECTION INDUCED BY BACTERIAL ENDOTOXIN AGAINST WHOLE-BODY X-IRRADIATION IN GERMFREE AND CONVENTIONAL MICE.
    LEDNEY GD; WILSON R
    Proc Soc Exp Biol Med; 1965 Apr; 118():1062-5. PubMed ID: 14277665
    [No Abstract]   [Full Text] [Related]  

  • 52. HYPERFIBRINOGENEMIA AND THROMBOCYTOPENIA AFTER STAPHYLOCOCCAL ENTEROTOXIN.
    SUGIYAMA H; MCKISSIC EM; HAYAMA T
    Proc Soc Exp Biol Med; 1964 Dec; 117():726-9. PubMed ID: 14244937
    [No Abstract]   [Full Text] [Related]  

  • 53. Chromogenic assay of endotoxin in platelet poor or rich plasma.
    Tachiyama G; Sakon M; Kambayashi J; Ohshiro T; Mori T
    Thromb Res; 1986 Feb; 41(3):309-17. PubMed ID: 3518136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
    Gerotziafas GT; Chakroun T; Depasse F; Arzoglou P; Samama MM; Elalamy I
    Thromb Haemost; 2004 May; 91(5):977-85. PubMed ID: 15116259
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival.
    Groves HM; Kinlough-Rathbone RL; Richardson M; Jørgensen L; Moore S; Mustard JF
    Lab Invest; 1982 Jun; 46(6):605-12. PubMed ID: 7087391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ENDOTOXEMIA AND ADRENAL HEMORRHAGE. A MECHANISM FOR THE WATERHOUSE-FRIDERICHSEN SYNDROME.
    LEVIN J; CLUFF LE
    J Exp Med; 1965 Feb; 121(2):247-60. PubMed ID: 14264270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variation in activities of non-plasmin fibrinolytic proteinase and plasminogen-activator in the lung and spleen induced by bacterial endotoxin in rats with special reference to the effects of MD-805.
    Okamoto U; Nagamatsu Y; Horie N; Yamamoto J; Sasaki K
    Thromb Haemost; 1985 Jun; 53(3):323-7. PubMed ID: 3901390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation.
    Ponert JM; Schwarz S; Haschemi R; Müller J; Pötzsch B; Bendas G; Schlesinger M
    PLoS One; 2018; 13(1):e0191303. PubMed ID: 29346400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IRON TRANSPORT AFTER INJECTION OF ENDOTOXIN IN RATS.
    KAMPSCHMIDT RF; UPCHURCH HF; JOHNSON HL
    Am J Physiol; 1965 Jan; 208():68-72. PubMed ID: 14253159
    [No Abstract]   [Full Text] [Related]  

  • 60. An ultrastructural study of the mechanisms of platelet-endotoxin interaction.
    Spielvogel AR
    J Exp Med; 1967 Aug; 126(2):235-50. PubMed ID: 4961486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.